| Bioactivity | Isoacteoside is a natural compound which exhibit significant inhibition of advanced glycation end product formation with IC50 values of 4.6-25.7 μM, compared with those of aminoguanidine (IC50=1,056 μM) and quercetin (IC50=28.4 μM) as positive controls.IC50 value:Target:In the rat lens aldose reductase assay, acteoside, isoacteoside, and poliumoside exhibited greater inhibitory effects on rat lens aldose reductase with IC50 values of 0.83, 0.83, and 0.85 μM, respectively, than those of the positive controls, 3,3-tetramethyleneglutaric acid (IC50=4.03 μM) and quercetin (IC50=7.2 μM). |
| Name | Isoacteoside |
| CAS | 61303-13-7 |
| Formula | C29H36O15 |
| Molar Mass | 624.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Isoacteoside
CAS: 61303-13-7 F: C29H36O15 W: 624.59
Isoacteoside is a natural compound which exhibit significant inhibition of advanced glycation end product formation with
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.